Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000263010

Medchemexpress LLC Iacs-8803 diammonium | 00-00-0 | 98.8% | 726.60 g/mol | C20H29FN12O9P2S2 | 5 MG
SDP

Catalog No. 5000263010
Encompass_Preferred

IACS-8803 diammonium is a potent cyclic dinucleotide STING agonist for preclinical research that activates the STING pathway and has demonstrated systemic antitumor efficacy. The diammonium salt form improves stability for handling and experimental use and is supplied with supporting analytical and safety documentation for research workflows.

  • High purity suitable for research use (98.8%).
  • Potent STING agonist activity for immuno-oncology studies.
  • Suitable for both in vitro and in vivo preclinical experiments.
  • Provided with SDS, COA, HNMR, LCMS, and analytical reports.
  • Available in multiple small research pack sizes for dose-ranging studies.

Catalog No. 50-002-63010 Supplier Medchemexpress LLC Supplier No. HY130115B5MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

IACS-8803 diammonium is a potent cyclic dinucleotide STING agonist for preclinical research that activates the STING pathway and has demonstrated systemic antitumor efficacy. The diammonium salt form improves stability for handling and experimental use and is supplied with supporting analytical and safety documentation for research workflows.

  • High purity suitable for research use (98.8%).
  • Potent STING agonist activity for immuno-oncology studies.
  • Suitable for both in vitro and in vivo preclinical experiments.
  • Provided with SDS, COA, HNMR, LCMS, and analytical reports.
  • Available in multiple small research pack sizes for dose-ranging studies.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.